What Is 3-Hydroxybutyryl-CoA dehydrogenase

Content on WhatAnswers is provided "as is" for informational purposes. While we strive for accuracy, we make no guarantees. Content is AI-assisted and should not be used as professional advice.

Last updated: April 15, 2026

Quick Answer: 3-Hydroxybutyryl-CoA dehydrogenase is an enzyme that catalyzes the oxidation of 3-hydroxybutyryl-CoA to 3-ketobutyryl-CoA, using NAD+ as a cofactor. It plays a critical role in the metabolism of fatty acids and ketone bodies, particularly in the beta-oxidation pathway.

Key Facts

The enzyme EC number for 3-Hydroxybutyryl-CoA dehydrogenase is 1.1.1.157
It operates primarily in mitochondria and peroxisomes of liver and muscle cells
The reaction it catalyzes is reversible and NAD+-dependent
Deficiency in this enzyme is linked to rare metabolic disorders like 3-hydroxybutyryl-CoA dehydrogenase deficiency
The human gene encoding this enzyme is HBDH, located on chromosome 12p11.2

Overview

3-Hydroxybutyryl-CoA dehydrogenase is a specialized enzyme involved in the intermediary metabolism of fatty acids and ketone bodies. It functions within the mitochondrial matrix, where it facilitates a key step in the beta-oxidation of fatty acids, particularly during periods of fasting or prolonged exercise.

This enzyme is essential for energy homeostasis, helping convert fatty acids into usable energy via acetyl-CoA production. Its activity is tightly regulated by cellular energy demands and redox state, ensuring metabolic efficiency under varying physiological conditions.

Enzyme classification: It is classified under EC 1.1.1.157, indicating it is an oxidoreductase acting on the CH-OH group of donors with NAD+ or NADP+ as acceptor.
Substrate specificity: The enzyme specifically acts on 3-hydroxybutyryl-CoA, converting it to 3-ketobutyryl-CoA in an NAD+-dependent oxidation reaction.
Cellular location: It is predominantly found in mitochondria, with minor activity detected in peroxisomes, especially in liver and skeletal muscle tissues.
Gene encoding: In humans, the enzyme is encoded by the HBDH gene located on chromosome 12p11.2, which spans approximately 18 kb and contains 9 exons.
Metabolic pathway: It plays a pivotal role in the final stages of fatty acid beta-oxidation, contributing to the production of acetyl-CoA for the citric acid cycle.

How It Works

The mechanism of 3-hydroxybutyryl-CoA dehydrogenase involves precise molecular interactions that enable the reversible oxidation of its substrate. Each catalytic event is dependent on NAD+ as a cofactor, which is reduced to NADH during the reaction.

Reaction type:It catalyzes a reversible oxidation of 3-hydroxybutyryl-CoA to form 3-ketobutyryl-CoA, with NAD+ reduced to NADH in the process, maintaining redox balance.
Active site structure:The enzyme features a Rossmann fold typical of NAD-binding proteins, allowing tight interaction with the cofactor and ensuring efficient electron transfer.
Kinetic parameters:The Km for 3-hydroxybutyryl-CoA is approximately 15 μM, indicating high substrate affinity, while Vmax values vary by tissue type and metabolic state.
pH optimum:Maximum activity occurs at pH 8.5–9.0, reflecting the alkaline environment of the mitochondrial matrix where it operates.
Temperature sensitivity:Optimal activity is observed at 37°C, consistent with human physiological conditions, and activity declines sharply above 45°C due to denaturation.
Regulatory control:Enzyme activity is modulated by NADH/NAD+ ratio, with high NADH levels inhibiting the forward reaction, thus preventing unnecessary energy expenditure.

Comparison at a Glance

Comparing 3-hydroxybutyryl-CoA dehydrogenase with related enzymes highlights its unique role in metabolism.

Enzyme	EC Number	Primary Substrate	Cellular Location	Key Function
3-Hydroxybutyryl-CoA dehydrogenase	1.1.1.157	3-Hydroxybutyryl-CoA	Mitochondria	Converts 3-hydroxybutyryl-CoA to 3-ketobutyryl-CoA
Hydroxyacyl-CoA dehydrogenase	1.1.1.35	L-3-Hydroxyacyl-CoA	Mitochondria	Acts on medium-chain fatty acid intermediates
Acetoacetyl-CoA thiolase	2.3.1.9	Acetoacetyl-CoA	Cytosol, mitochondria	Converts acetoacetyl-CoA to acetyl-CoA
3-Hydroxyisobutyryl-CoA hydrolase	3.1.2.4	3-Hydroxyisobutyryl-CoA	Mitochondria	Hydrolyzes CoA esters in valine catabolism
Alcohol dehydrogenase	1.1.1.1	Alcohols	Cytosol	Metabolizes ethanol and other alcohols

This comparison shows that while several enzymes handle CoA-linked intermediates, 3-hydroxybutyryl-CoA dehydrogenase is uniquely specialized for its substrate and pathway. Its mitochondrial localization and NAD+ dependence distinguish it from cytosolic dehydrogenases, emphasizing its role in energy metabolism rather than detoxification.

Why It Matters

Understanding this enzyme is crucial for diagnosing and managing metabolic disorders linked to fatty acid oxidation defects. Its function directly impacts energy availability, especially during fasting, making it vital for metabolic health.

Metabolic disease marker:Mutations in HBDH can lead to 3-hydroxybutyryl-CoA dehydrogenase deficiency, a rare condition causing hypoglycemia, lethargy, and metabolic acidosis in infants.
Diagnostic utility:Elevated 3-hydroxybutyryl-carnitine in blood plasma is a biomarker used in newborn screening for fatty acid oxidation disorders.
Therapeutic target:Modulating its activity could help manage conditions like type 2 diabetes by improving mitochondrial efficiency and ketone utilization.
Energy during fasting:The enzyme supports ketone body metabolism, providing an alternative energy source for the brain and heart when glucose is scarce.
Evolutionary conservation:Homologs exist in bacteria and yeast, indicating its fundamental role in cellular energy production across species.
Biotechnological applications:Engineered variants are used in synthetic biology to optimize biofuel production from fatty acid derivatives.

Due to its central role in metabolism, ongoing research continues to explore the enzyme’s potential in both clinical and industrial settings. Advances in genetic screening and enzyme kinetics are enhancing our ability to diagnose and treat related disorders effectively.